| Dr Jonathan B Zuckerman, MD | |
|
100 Foden Road, West Building Suite 103, South Portland, ME 04106 | |
| (207) 828-1122 | |
| (207) 828-0188 |
| Full Name | Dr Jonathan B Zuckerman |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 37 Years |
| Location | 100 Foden Road, South Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043313356 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 015233 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chest Medicine Associates Pa | 0547258931 | 23 |
| Mainehealth | 7517860588 | 2067 |
News Archive
Prescription opioid headlines are staggering: 40 Americans die each day from overdoses involving prescription opioids; they cost the United States economy $78.5 billion a year; and 227 million opioid prescriptions were handed out in the U.S. in 2015.
Scientific data suggest that a woman reduces her risk of breast cancer by breastfeeding, having multiple children and giving birth at a younger age. A study led by the University of California, San Diego School of Medicine and recently published online by Cancer Epidemiology, Biomarkers & Prevention, indicates that women of Mexican descent may not fit that profile. In fact, results suggest that women of Mexican descent with more children and those who breastfeed are more likely to be diagnosed with an aggressive form of breast cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce the powerful, NuGenius gel imaging system. This easy-to-use system quickly generates high quality images of DNA gels and will suit laboratories looking for a sensitive, affordable routine gel imager.
This year's prestigious Canadian Prix Galien for Innovative Product Award has been presented to Esbriet (pirfenidone), a medicine used to treat idiopathic pulmonary fibrosis (IPF). It is the only medication approved in Canada with a specific IPF indication and is approved for mild to moderate IPF in adults.
› Verified 6 days ago
| Entity Name | Chest Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437255247 PECOS PAC ID: 0547258931 Enrollment ID: O20040504001161 |
News Archive
Prescription opioid headlines are staggering: 40 Americans die each day from overdoses involving prescription opioids; they cost the United States economy $78.5 billion a year; and 227 million opioid prescriptions were handed out in the U.S. in 2015.
Scientific data suggest that a woman reduces her risk of breast cancer by breastfeeding, having multiple children and giving birth at a younger age. A study led by the University of California, San Diego School of Medicine and recently published online by Cancer Epidemiology, Biomarkers & Prevention, indicates that women of Mexican descent may not fit that profile. In fact, results suggest that women of Mexican descent with more children and those who breastfeed are more likely to be diagnosed with an aggressive form of breast cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce the powerful, NuGenius gel imaging system. This easy-to-use system quickly generates high quality images of DNA gels and will suit laboratories looking for a sensitive, affordable routine gel imager.
This year's prestigious Canadian Prix Galien for Innovative Product Award has been presented to Esbriet (pirfenidone), a medicine used to treat idiopathic pulmonary fibrosis (IPF). It is the only medication approved in Canada with a specific IPF indication and is approved for mild to moderate IPF in adults.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Prescription opioid headlines are staggering: 40 Americans die each day from overdoses involving prescription opioids; they cost the United States economy $78.5 billion a year; and 227 million opioid prescriptions were handed out in the U.S. in 2015.
Scientific data suggest that a woman reduces her risk of breast cancer by breastfeeding, having multiple children and giving birth at a younger age. A study led by the University of California, San Diego School of Medicine and recently published online by Cancer Epidemiology, Biomarkers & Prevention, indicates that women of Mexican descent may not fit that profile. In fact, results suggest that women of Mexican descent with more children and those who breastfeed are more likely to be diagnosed with an aggressive form of breast cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce the powerful, NuGenius gel imaging system. This easy-to-use system quickly generates high quality images of DNA gels and will suit laboratories looking for a sensitive, affordable routine gel imager.
This year's prestigious Canadian Prix Galien for Innovative Product Award has been presented to Esbriet (pirfenidone), a medicine used to treat idiopathic pulmonary fibrosis (IPF). It is the only medication approved in Canada with a specific IPF indication and is approved for mild to moderate IPF in adults.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan B Zuckerman, MD 100 Foden Road, West Building Suite 103, South Portland, ME 04106 Ph: (207) 828-1122 | Dr Jonathan B Zuckerman, MD 100 Foden Road, West Building Suite 103, South Portland, ME 04106 Ph: (207) 828-1122 |
News Archive
Prescription opioid headlines are staggering: 40 Americans die each day from overdoses involving prescription opioids; they cost the United States economy $78.5 billion a year; and 227 million opioid prescriptions were handed out in the U.S. in 2015.
Scientific data suggest that a woman reduces her risk of breast cancer by breastfeeding, having multiple children and giving birth at a younger age. A study led by the University of California, San Diego School of Medicine and recently published online by Cancer Epidemiology, Biomarkers & Prevention, indicates that women of Mexican descent may not fit that profile. In fact, results suggest that women of Mexican descent with more children and those who breastfeed are more likely to be diagnosed with an aggressive form of breast cancer.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce the powerful, NuGenius gel imaging system. This easy-to-use system quickly generates high quality images of DNA gels and will suit laboratories looking for a sensitive, affordable routine gel imager.
This year's prestigious Canadian Prix Galien for Innovative Product Award has been presented to Esbriet (pirfenidone), a medicine used to treat idiopathic pulmonary fibrosis (IPF). It is the only medication approved in Canada with a specific IPF indication and is approved for mild to moderate IPF in adults.
› Verified 6 days ago
Laureen A Biczak, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-774-5816 Fax: 207-523-8594 | |
Pamela Egan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Sylvia Vania Alarcon Velasco, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 265 Western Ave Ste 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Dr. Christopher G Tretter, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Mainehealth Cancer Care, 265 Western Ave Suite 2, South Portland, ME 04106 Phone: 207-661-0200 | |
Dr. Emily V Wood, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 50 Foden Rd, Ste 3, South Portland, ME 04106 Phone: 207-774-5816 Fax: 207-523-8594 | |
Dr. Daniel J Diekema, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 41 Donald B Dean Dr, South Portland, ME 04106 Phone: 207-661-7901 |